Tenet Healthcare Corporation (NYSE: THC) announced today the pricing of its previously announced private offering of senior secured notes maturing in 2021. A total of $850 million aggregate principal amount of senior secured notes, which will bear interest at a rate of 4.5% per annum, will be issued. The senior secured notes will rank senior to Tenet’s existing and future subordinated indebtedness, be effectively senior to Tenet’s existing and future unsecured indebtedness and other liabilities to the extent of the value of the collateral securing the senior secured notes or guarantees thereon, and will rank pari passu with Tenet’s 6.25% senior secured notes due 2018, which were issued in November 2011 and April 2012, any 10% senior secured notes due 2018 that are not tendered in the tender offered mentioned below, which were issued in March 2009, its 8.875% senior secured notes due 2019, which were issued in June 2009 and its 4.750% senior secured notes due 2020, which were issued in October 2012, and similarly will be guaranteed by and secured by a pledge of the capital stock and other ownership interests of certain of Tenet’s subsidiaries, and will be subordinated to Tenet’s obligations under its senior secured revolving credit facility, and any of its subsidiaries’ secured guarantees thereof, to the extent of the value of the collateral securing borrowings under such facility. The proceeds from the offering will be used to purchase Tenet’s 10% senior secured notes due 2018 in a tender offer. Tenet will use any remaining net proceeds for purchases of its outstanding senior secured notes through public or privately negotiated transactions, and for general corporate purposes, including the repayment of indebtedness and drawings under its senior secured revolving credit facility and strategic acquisitions. The offering of the senior secured notes is expected to close on February 5, 2013, subject to customary closing conditions.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts